HAP Trading’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,300
Closed -$3.67K 733
2024
Q4
$3.67K Sell
10,300
-24,700
-71% -$2.27M ﹤0.01% 666
2024
Q3
$91K Buy
+35,000
New +$3.06M 0.05% 407
2023
Q1
Sell
-14,300
Closed -$293K 1256
2022
Q4
$293K Sell
14,300
-2,800
-16% -$167K 0.05% 388
2022
Q3
$85K Buy
17,100
+1,400
+9% +$70K 0.01% 830
2022
Q2
$107K Buy
15,700
+2,100
+15% +$66.4K 0.01% 868
2022
Q1
$127K Sell
13,600
-12,700
-48% -$394K 0.01% 974
2021
Q4
$124K Buy
26,300
+11,900
+83% +$438K 0.01% 1165
2021
Q3
$94K Buy
14,400
+2,600
+22% +$101K 0.01% 1269
2021
Q2
$62K Buy
+11,800
New +$708K ﹤0.01% 1394
2021
Q1
Sell
-17,400
Closed -$97K 2016
2020
Q4
$97K Sell
17,400
-13,700
-44% -$1.02M 0.01% 1180
2020
Q3
$19K Sell
31,100
-81,200
-72% -$6.33M ﹤0.01% 1172
2020
Q2
$1.25M Sell
112,300
-49,500
-31% -$3.81M 0.14% 238
2020
Q1
$139K Sell
161,800
-11,900
-7% -$970K 0.02% 607
2019
Q4
$12M Buy
173,700
+160,600
+1,226% +$6.49M 0.89% 31
2019
Q3
$46K Buy
+13,100
New +$337K 0.01% 748

Other funds holding AXSM